speb/financial-data huggingface dataset:
PATH cash_flow (quarterly, 2025-10-31) — Net PPE Purchase And Sale: -3164000.00
PATH balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: 1782409000.00
PATH balance_sheet (quarterly, 2025-10-31) — Non Current Accounts Receivable: 4701000.00
PATH balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Assets: 350774000.00
PATH balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Liabilities: 99155000.00
PATH balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Revenue: 99155000.00
PATH balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Taxes Assets: 212999000.00
PATH income_statement (quarterly, 2025-10-31) — Normalized EBITDA: 17584000.00
PATH income_statement (quarterly, 2025-10-31) — Normalized Income: 198839000.00
PATH cash_flow (quarterly, 2025-10-31) — Operating Cash Flow: 28271000.00
PATH income_statement (quarterly, 2025-10-31) — Operating Income: 13071000.00
PATH income_statement (quarterly, 2025-10-31) — Operating Revenue: 411113000.00
PATH balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 534654000.00
PATH balance_sheet (quarterly, 2025-10-31) — Other Current Assets: 57171000.00
PATH balance_sheet (quarterly, 2025-10-31) — Other Current Liabilities: 35535000.00
PATH balance_sheet (quarterly, 2025-10-31) — Other Equity Adjustments: 27690000.00
PATH income_statement (quarterly, 2025-10-31) — Other Gand A: 53175000.00
PATH income_statement (quarterly, 2025-10-31) — Other Income Expense: -180000.00
PATH balance_sheet (quarterly, 2025-10-31) — Other Intangible Assets: 21583000.00
PATH cash_flow (quarterly, 2025-10-31) — Other Non Cash Items: 37932000.00
PATH balance_sheet (quarterly, 2025-10-31) — Other Non Current Assets: 73571000.00
PATH balance_sheet (quarterly, 2025-10-31) — Other Non Current Liabilities: 11488000.00
PATH income_statement (quarterly, 2025-10-31) — Other Non Operating Income Expenses: -180000.00
PATH balance_sheet (quarterly, 2025-10-31) — Other Properties: 65818000.00
PATH balance_sheet (quarterly, 2025-10-31) — Other Receivables: 129335000.00
PATH balance_sheet (quarterly, 2025-10-31) — Other Short Term Investments: 654526000.00
PATH balance_sheet (quarterly, 2025-10-31) — Payables: 59695000.00
PATH balance_sheet (quarterly, 2025-10-31) — Payables And Accrued Expenses: 105881000.00
PATH balance_sheet (quarterly, 2025-10-31) — Pensionand Other Post Retirement Benefit Plans Current: 95293000.00
PATH balance_sheet (quarterly, 2025-10-31) — Preferred Stock: 0.00
PATH balance_sheet (quarterly, 2025-10-31) — Prepaid Assets: 54957000.00
PATH income_statement (quarterly, 2025-10-31) — Pretax Income: 24592000.00
PATH cash_flow (quarterly, 2025-10-31) — Proceeds From Stock Option Exercised: 4239000.00
PATH balance_sheet (quarterly, 2025-10-31) — Properties: 0.00
PATH cash_flow (quarterly, 2025-10-31) — Purchase Of Business: 0.00
PATH cash_flow (quarterly, 2025-10-31) — Purchase Of Investment: -207180000.00
PATH cash_flow (quarterly, 2025-10-31) — Purchase Of PPE: -3164000.00
PATH balance_sheet (quarterly, 2025-10-31) — Receivables: 496092000.00
PATH income_statement (quarterly, 2025-10-31) — Reconciled Cost Of Revenue: 68812000.00
PATH income_statement (quarterly, 2025-10-31) — Reconciled Depreciation: 4513000.00
PATH cash_flow (quarterly, 2025-10-31) — Repurchase Of Capital Stock: 0.00
PATH income_statement (quarterly, 2025-10-31) — Research And Development: 96869000.00
PATH balance_sheet (quarterly, 2025-10-31) — Restricted Cash: 438000.00
PATH balance_sheet (quarterly, 2025-10-31) — Retained Earnings: -1810007000.00
PATH cash_flow (quarterly, 2025-10-31) — Sale Of Investment: 327947000.00
PATH income_statement (quarterly, 2025-10-31) — Selling And Marketing Expense: 179186000.00
PATH income_statement (quarterly, 2025-10-31) — Selling General And Administration: 232361000.00
PATH balance_sheet (quarterly, 2025-10-31) — Share Issued: 602426000.00
PATH cash_flow (quarterly, 2025-10-31) — Stock Based Compensation: 71475000.00
PATH balance_sheet (quarterly, 2025-10-31) — Stockholders Equity: 1924617000.00
PATH balance_sheet (quarterly, 2025-10-31) — Tangible Book Value: 1782409000.00
PATH income_statement (quarterly, 2025-10-31) — Tax Effect Of Unusual Items: 0.00
PATH income_statement (quarterly, 2025-10-31) — Tax Provision: -174247000.00
PATH income_statement (quarterly, 2025-10-31) — Tax Rate For Calcs: 0.21
PATH balance_sheet (quarterly, 2025-10-31) — Total Assets: 2895976000.00
PATH balance_sheet (quarterly, 2025-10-31) — Total Capitalization: 1924617000.00
PATH balance_sheet (quarterly, 2025-10-31) — Total Debt: 82009000.00
PATH balance_sheet (quarterly, 2025-10-31) — Total Equity Gross Minority Interest: 1924617000.00
PATH income_statement (quarterly, 2025-10-31) — Total Expenses: 398042000.00
PATH balance_sheet (quarterly, 2025-10-31) — Total Liabilities Net Minority Interest: 971359000.00
PATH balance_sheet (quarterly, 2025-10-31) — Total Non Current Assets: 802633000.00
PATH balance_sheet (quarterly, 2025-10-31) — Total Non Current Liabilities Net Minority Interest: 182659000.00
PATH income_statement (quarterly, 2025-10-31) — Total Operating Income As Reported: 13071000.00
PATH balance_sheet (quarterly, 2025-10-31) — Total Tax Payable: 32325000.00
PATH balance_sheet (quarterly, 2025-10-31) — Treasury Shares Number: 67772000.00
PATH balance_sheet (quarterly, 2025-10-31) — Treasury Stock: 824329000.00
PATH balance_sheet (quarterly, 2025-10-31) — Working Capital: 1304643000.00
PATH income_statement (annual, 2026-01-31) — +Operating Expense: 1282828000.00
PATH income_statement (quarterly, 2026-01-31) — +Operating Expense: 326886000.00
PATH income_statement (annual, 2026-01-31) — +Total Revenue: 1610572000.00
PATH income_statement (quarterly, 2026-01-31) — +Total Revenue: 481107000.00
PATH balance_sheet (annual, 2026-01-31) — Accounts Payable: 10161000.00
PATH balance_sheet (quarterly, 2026-01-31) — Accounts Payable: 10161000.00
PATH balance_sheet (annual, 2026-01-31) — Accounts Receivable: 488265000.00
PATH balance_sheet (quarterly, 2026-01-31) — Accounts Receivable: 488265000.00
PATH balance_sheet (annual, 2026-01-31) — Accumulated Depreciation: -45887000.00
PATH balance_sheet (quarterly, 2026-01-31) — Accumulated Depreciation: -45887000.00
PATH balance_sheet (annual, 2026-01-31) — Additional Paid In Capital: 4585430000.00
PATH balance_sheet (quarterly, 2026-01-31) — Additional Paid In Capital: 4585430000.00
PATH balance_sheet (annual, 2026-01-31) — Allowance For Doubtful Accounts Receivable: -5222000.00
PATH balance_sheet (quarterly, 2026-01-31) — Allowance For Doubtful Accounts Receivable: -5222000.00
PATH cash_flow (annual, 2026-01-31) — Amortization Of Securities: -10236000.00
PATH cash_flow (quarterly, 2026-01-31) — Amortization Of Securities: -1189000.00
PATH balance_sheet (annual, 2026-01-31) — Available For Sale Securities: 216990000.00
PATH balance_sheet (quarterly, 2026-01-31) — Available For Sale Securities: 216990000.00
PATH income_statement (annual, 2026-01-31) — Basic Average Shares: 538125000.00
PATH income_statement (quarterly, 2026-01-31) — Basic Average Shares: 535962000.00
PATH income_statement (annual, 2026-01-31) — Basic EPS: 0.52
PATH income_statement (quarterly, 2026-01-31) — Basic EPS: 0.19
PATH cash_flow (annual, 2026-01-31) — Beginning Cash Position: 879634000.00
PATH cash_flow (quarterly, 2026-01-31) — Beginning Cash Position: 744098000.00
PATH cash_flow (annual, 2026-01-31) — Capital Expenditure: -19048000.00
PATH cash_flow (quarterly, 2026-01-31) — Capital Expenditure: -3052000.00
PATH balance_sheet (annual, 2026-01-31) — Capital Lease Obligations: 81246000.00
PATH balance_sheet (quarterly, 2026-01-31) — Capital Lease Obligations: 81246000.00
PATH balance_sheet (annual, 2026-01-31) — Capital Stock: 6000.00
PATH balance_sheet (quarterly, 2026-01-31) — Capital Stock: 6000.00
PATH balance_sheet (annual, 2026-01-31) — Cash And Cash Equivalents: 871157000.00
PATH balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 871157000.00
PATH balance_sheet (annual, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 1472486000.00
PATH balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 1472486000.00
PATH cash_flow (annual, 2026-01-31) — Cash Flow From Continuing Financing Activities: -372375000.00
PATH cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Financing Activities: -14402000.00
PATH cash_flow (annual, 2026-01-31) — Cash Flow From Continuing Investing Activities: -22466000.00
PATH cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Investing Activities: -42652000.00
PATH cash_flow (annual, 2026-01-31) — Cash Flow From Continuing Operating Activities: 371208000.00
PATH cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Operating Activities: 182348000.00
PATH cash_flow (annual, 2026-01-31) — Change In Account Payable: -21675000.00
PATH cash_flow (quarterly, 2026-01-31) — Change In Account Payable: -4274000.00
PATH cash_flow (annual, 2026-01-31) — Change In Accrued Expense: 49280000.00
PATH cash_flow (quarterly, 2026-01-31) — Change In Accrued Expense: 42099000.00
PATH cash_flow (annual, 2026-01-31) — Change In Other Current Liabilities: -11652000.00
PATH cash_flow (quarterly, 2026-01-31) — Change In Other Current Liabilities: -4200000.00
PATH cash_flow (annual, 2026-01-31) — Change In Other Working Capital: -138633000.00
PATH cash_flow (quarterly, 2026-01-31) — Change In Other Working Capital: 19032000.00
PATH cash_flow (annual, 2026-01-31) — Change In Payable: -21675000.00
PATH cash_flow (quarterly, 2026-01-31) — Change In Payable: -4274000.00
PATH cash_flow (annual, 2026-01-31) — Change In Payables And Accrued Expense: 27605000.00
PATH cash_flow (quarterly, 2026-01-31) — Change In Payables And Accrued Expense: 37825000.00
PATH cash_flow (annual, 2026-01-31) — Change In Prepaid Assets: -3933000.00
PATH cash_flow (quarterly, 2026-01-31) — Change In Prepaid Assets: 6445000.00
PATH cash_flow (annual, 2026-01-31) — Change In Receivables: -22594000.00
PATH cash_flow (quarterly, 2026-01-31) — Change In Receivables: -78905000.00
PATH cash_flow (annual, 2026-01-31) — Change In Working Capital: -149207000.00
PATH cash_flow (quarterly, 2026-01-31) — Change In Working Capital: -19803000.00
PATH cash_flow (annual, 2026-01-31) — Changes In Account Receivables: -25802000.00
PATH cash_flow (quarterly, 2026-01-31) — Changes In Account Receivables: -119259000.00
PATH cash_flow (annual, 2026-01-31) — Changes In Cash: -23633000.00
PATH cash_flow (quarterly, 2026-01-31) — Changes In Cash: 125294000.00
PATH balance_sheet (annual, 2026-01-31) — Common Stock: 6000.00
PATH balance_sheet (quarterly, 2026-01-31) — Common Stock: 6000.00
PATH balance_sheet (annual, 2026-01-31) — Common Stock Equity: 2082587000.00
PATH balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 2082587000.00
PATH cash_flow (annual, 2026-01-31) — Common Stock Payments: -329101000.00
PATH cash_flow (quarterly, 2026-01-31) — Common Stock Payments: 0.00
PATH balance_sheet (annual, 2026-01-31) — Construction In Progress: 4103000.00
PATH balance_sheet (quarterly, 2026-01-31) — Construction In Progress: 4103000.00
PATH income_statement (annual, 2026-01-31) — Cost Of Revenue: 270984000.00
PATH income_statement (quarterly, 2026-01-31) — Cost Of Revenue: 73935000.00
PATH balance_sheet (annual, 2026-01-31) — Current Accrued Expenses: 42087000.00
PATH balance_sheet (quarterly, 2026-01-31) — Current Accrued Expenses: 42087000.00
PATH balance_sheet (annual, 2026-01-31) — Current Assets: 2243945000.00
PATH balance_sheet (quarterly, 2026-01-31) — Current Assets: 2243945000.00
PATH balance_sheet (annual, 2026-01-31) — Current Capital Lease Obligation: 10306000.00
PATH balance_sheet (quarterly, 2026-01-31) — Current Capital Lease Obligation: 10306000.00
PATH balance_sheet (annual, 2026-01-31) — Current Debt And Capital Lease Obligation: 10306000.00
PATH balance_sheet (quarterly, 2026-01-31) — Current Debt And Capital Lease Obligation: 10306000.00
PATH balance_sheet (annual, 2026-01-31) — Current Deferred Assets: 84739000.00
PATH balance_sheet (quarterly, 2026-01-31) — Current Deferred Assets: 84739000.00
PATH balance_sheet (annual, 2026-01-31) — Current Deferred Liabilities: 611737000.00
PATH balance_sheet (quarterly, 2026-01-31) — Current Deferred Liabilities: 611737000.00
PATH balance_sheet (annual, 2026-01-31) — Current Deferred Revenue: 603737000.00
PATH balance_sheet (quarterly, 2026-01-31) — Current Deferred Revenue: 603737000.00
PATH balance_sheet (annual, 2026-01-31) — Current Liabilities: 905423000.00
PATH balance_sheet (quarterly, 2026-01-31) — Current Liabilities: 905423000.00
PATH cash_flow (annual, 2026-01-31) — Deferred Income Tax: -202682000.00
PATH cash_flow (quarterly, 2026-01-31) — Deferred Income Tax: -15372000.00
PATH cash_flow (annual, 2026-01-31) — Deferred Tax: -202682000.00
PATH cash_flow (quarterly, 2026-01-31) — Deferred Tax: -15372000.00
PATH cash_flow (annual, 2026-01-31) — Depreciation Amortization Depletion: 16969000.00
PATH cash_flow (quarterly, 2026-01-31) — Depreciation Amortization Depletion: 4973000.00
PATH cash_flow (annual, 2026-01-31) — Depreciation And Amortization: 16969000.00
PATH cash_flow (quarterly, 2026-01-31) — Depreciation And Amortization: 4973000.00
PATH income_statement (annual, 2026-01-31) — Diluted Average Shares: 544860000.00
PATH income_statement (quarterly, 2026-01-31) — Diluted Average Shares: 545284000.00
PATH income_statement (annual, 2026-01-31) — Diluted EPS: 0.52
PATH income_statement (quarterly, 2026-01-31) — Diluted EPS: 0.19
PATH income_statement (annual, 2026-01-31) — Diluted NI Availto Com Stockholders: 282330000.00
PATH income_statement (quarterly, 2026-01-31) — Diluted NI Availto Com Stockholders: 104462000.00
PATH balance_sheet (annual, 2026-01-31) — Dueto Related Parties Current: 12345000.00
PATH balance_sheet (quarterly, 2026-01-31) — Dueto Related Parties Current: 12345000.00
PATH income_statement (annual, 2026-01-31) — EBIT: 56760000.00
PATH income_statement (quarterly, 2026-01-31) — EBIT: 80286000.00
PATH income_statement (annual, 2026-01-31) — EBITDA: 73729000.00
PATH income_statement (quarterly, 2026-01-31) — EBITDA: 85259000.00
PATH cash_flow (annual, 2026-01-31) — Effect Of Exchange Rate Changes: 15594000.00
PATH cash_flow (quarterly, 2026-01-31) — Effect Of Exchange Rate Changes: 2203000.00
PATH cash_flow (annual, 2026-01-31) — End Cash Position: 871595000.00
PATH cash_flow (quarterly, 2026-01-31) — End Cash Position: 871595000.00
PATH cash_flow (annual, 2026-01-31) — Financing Cash Flow: -372375000.00
PATH cash_flow (quarterly, 2026-01-31) — Financing Cash Flow: -14402000.00
PATH cash_flow (annual, 2026-01-31) — Free Cash Flow: 352160000.00
PATH cash_flow (quarterly, 2026-01-31) — Free Cash Flow: 179296000.00
PATH balance_sheet (annual, 2026-01-31) — Gains Losses Not Affecting Retained Earnings: 36601000.00
PATH balance_sheet (quarterly, 2026-01-31) — Gains Losses Not Affecting Retained Earnings: 36601000.00
PATH income_statement (annual, 2026-01-31) — General And Administrative Expense: 214291000.00
PATH income_statement (quarterly, 2026-01-31) — General And Administrative Expense: 53548000.00
PATH balance_sheet (annual, 2026-01-31) — Goodwill: 125310000.00
PATH balance_sheet (quarterly, 2026-01-31) — Goodwill: 125310000.00
PATH balance_sheet (annual, 2026-01-31) — Goodwill And Other Intangible Assets: 145299000.00
PATH balance_sheet (quarterly, 2026-01-31) — Goodwill And Other Intangible Assets: 145299000.00
PATH balance_sheet (annual, 2026-01-31) — Gross Accounts Receivable: 493487000.00
PATH balance_sheet (quarterly, 2026-01-31) — Gross Accounts Receivable: 493487000.00
PATH balance_sheet (annual, 2026-01-31) — Gross PPE: 156373000.00
PATH balance_sheet (quarterly, 2026-01-31) — Gross PPE: 156373000.00
PATH income_statement (annual, 2026-01-31) — Gross Profit: 1339588000.00
PATH income_statement (quarterly, 2026-01-31) — Gross Profit: 407172000.00
PATH cash_flow (annual, 2026-01-31) — Income Tax Paid Supplemental Data: 9812000.00
PATH cash_flow (quarterly, 2026-01-31) — Income Tax Paid Supplemental Data: -2766000.00
PATH balance_sheet (annual, 2026-01-31) — Income Tax Payable: 14784000.00
PATH balance_sheet (quarterly, 2026-01-31) — Income Tax Payable: 14784000.00
PATH income_statement (annual, 2026-01-31) — Interest Income: 48023000.00
PATH income_statement (quarterly, 2026-01-31) — Interest Income: 11670000.00
PATH income_statement (annual, 2026-01-31) — Interest Income Non Operating: 48023000.00
PATH income_statement (quarterly, 2026-01-31) — Interest Income Non Operating: 11670000.00
PATH cash_flow (annual, 2026-01-31) — Interest Paid Supplemental Data: 0.00
PATH cash_flow (quarterly, 2026-01-31) — Interest Paid Supplemental Data: 0.00
PATH balance_sheet (annual, 2026-01-31) — Invested Capital: 2082587000.00
PATH balance_sheet (quarterly, 2026-01-31) — Invested Capital: 2082587000.00
PATH cash_flow (annual, 2026-01-31) — Investing Cash Flow: -22466000.00
PATH cash_flow (quarterly, 2026-01-31) — Investing Cash Flow: -42652000.00
PATH balance_sheet (annual, 2026-01-31) — Investmentin Financial Assets: 216990000.00
PATH balance_sheet (quarterly, 2026-01-31) — Investmentin Financial Assets: 216990000.00
PATH balance_sheet (annual, 2026-01-31) — Investments And Advances: 216990000.00
PATH balance_sheet (quarterly, 2026-01-31) — Investments And Advances: 216990000.00
PATH balance_sheet (annual, 2026-01-31) — Leases: 52578000.00
PATH balance_sheet (quarterly, 2026-01-31) — Leases: 52578000.00
PATH balance_sheet (annual, 2026-01-31) — Long Term Capital Lease Obligation: 70940000.00
PATH balance_sheet (quarterly, 2026-01-31) — Long Term Capital Lease Obligation: 70940000.00
PATH balance_sheet (annual, 2026-01-31) — Long Term Debt And Capital Lease Obligation: 70940000.00
PATH balance_sheet (quarterly, 2026-01-31) — Long Term Debt And Capital Lease Obligation: 70940000.00
PATH balance_sheet (annual, 2026-01-31) — Machinery Furniture Equipment: 34397000.00
PATH balance_sheet (quarterly, 2026-01-31) — Machinery Furniture Equipment: 34397000.00
PATH cash_flow (annual, 2026-01-31) — Net Business Purchase And Sale: -24821000.00
PATH cash_flow (quarterly, 2026-01-31) — Net Business Purchase And Sale: 0.00
PATH cash_flow (annual, 2026-01-31) — Net Common Stock Issuance: -329101000.00
PATH cash_flow (quarterly, 2026-01-31) — Net Common Stock Issuance: 0.00
PATH income_statement (annual, 2026-01-31) — Net Income: 282330000.00
PATH income_statement (quarterly, 2026-01-31) — Net Income: 104462000.00
PATH income_statement (annual, 2026-01-31) — Net Income Common Stockholders: 282330000.00
PATH income_statement (quarterly, 2026-01-31) — Net Income Common Stockholders: 104462000.00
PATH income_statement (annual, 2026-01-31) — Net Income Continuous Operations: 282330000.00
PATH income_statement (quarterly, 2026-01-31) — Net Income Continuous Operations: 104462000.00
PATH income_statement (annual, 2026-01-31) — Net Income From Continuing And Discontinued Operation: 282330000.00
PATH income_statement (quarterly, 2026-01-31) — Net Income From Continuing And Discontinued Operation: 104462000.00
PATH income_statement (annual, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: 282330000.00
PATH income_statement (quarterly, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: 104462000.00
PATH cash_flow (annual, 2026-01-31) — Net Income From Continuing Operations: 282330000.00
PATH cash_flow (quarterly, 2026-01-31) — Net Income From Continuing Operations: 104462000.00
PATH income_statement (annual, 2026-01-31) — Net Income Including Noncontrolling Interests: 282330000.00
PATH income_statement (quarterly, 2026-01-31) — Net Income Including Noncontrolling Interests: 104462000.00
PATH income_statement (annual, 2026-01-31) — Net Interest Income: 48023000.00
PATH income_statement (quarterly, 2026-01-31) — Net Interest Income: 11670000.00
PATH cash_flow (annual, 2026-01-31) — Net Investment Purchase And Sale: 36756000.00
PATH cash_flow (quarterly, 2026-01-31) — Net Investment Purchase And Sale: -41086000.00
PATH income_statement (annual, 2026-01-31) — Net Non Operating Interest Income Expense: 48023000.00
PATH income_statement (quarterly, 2026-01-31) — Net Non Operating Interest Income Expense: 11670000.00
PATH cash_flow (annual, 2026-01-31) — Net Other Financing Charges: -59189000.00
PATH cash_flow (quarterly, 2026-01-31) — Net Other Financing Charges: -17486000.00
PATH cash_flow (annual, 2026-01-31) — Net Other Investing Changes: -15353000.00
PATH cash_flow (quarterly, 2026-01-31) — Net Other Investing Changes: 1486000.00
PATH balance_sheet (annual, 2026-01-31) — Net PPE: 110486000.00
PATH balance_sheet (quarterly, 2026-01-31) — Net PPE: 110486000.00
PATH cash_flow (annual, 2026-01-31) — Net PPE Purchase And Sale: -19048000.00
PATH cash_flow (quarterly, 2026-01-31) — Net PPE Purchase And Sale: -3052000.00
PATH balance_sheet (annual, 2026-01-31) — Net Tangible Assets: 1937288000.00
PATH balance_sheet (quarterly, 2026-01-31) — Net Tangible Assets: 1937288000.00
PATH balance_sheet (annual, 2026-01-31) — Non Current Accounts Receivable: 1946000.00
PATH balance_sheet (quarterly, 2026-01-31) — Non Current Accounts Receivable: 1946000.00
PATH balance_sheet (annual, 2026-01-31) — Non Current Deferred Assets: 387109000.00
PATH balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Assets: 387109000.00
PATH balance_sheet (annual, 2026-01-31) — Non Current Deferred Liabilities: 103568000.00
PATH balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Liabilities: 103568000.00
PATH balance_sheet (annual, 2026-01-31) — Non Current Deferred Revenue: 103568000.00
PATH balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Revenue: 103568000.00
PATH balance_sheet (annual, 2026-01-31) — Non Current Deferred Taxes Assets: 233401000.00
PATH balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Taxes Assets: 233401000.00
PATH income_statement (annual, 2026-01-31) — Normalized EBITDA: 73729000.00
PATH income_statement (quarterly, 2026-01-31) — Normalized EBITDA: 85259000.00
PATH income_statement (annual, 2026-01-31) — Normalized Income: 282330000.00
PATH income_statement (quarterly, 2026-01-31) — Normalized Income: 104462000.00
PATH cash_flow (annual, 2026-01-31) — Operating Cash Flow: 371208000.00
PATH cash_flow (quarterly, 2026-01-31) — Operating Cash Flow: 182348000.00
PATH income_statement (annual, 2026-01-31) — Operating Income: 56760000.00
PATH income_statement (quarterly, 2026-01-31) — Operating Income: 80286000.00
PATH income_statement (annual, 2026-01-31) — Operating Revenue: 1610572000.00
PATH income_statement (quarterly, 2026-01-31) — Operating Revenue: 481107000.00
PATH balance_sheet (annual, 2026-01-31) — Ordinary Shares Number: 537037000.00
PATH balance_sheet (quarterly, 2026-01-31) — Ordinary Shares Number: 537037000.00
PATH balance_sheet (annual, 2026-01-31) — Other Current Assets: 50245000.00
PATH balance_sheet (quarterly, 2026-01-31) — Other Current Assets: 50245000.00
PATH balance_sheet (annual, 2026-01-31) — Other Current Liabilities: 50596000.00
PATH balance_sheet (quarterly, 2026-01-31) — Other Current Liabilities: 50596000.00
PATH balance_sheet (annual, 2026-01-31) — Other Equity Adjustments: 36601000.00
PATH balance_sheet (quarterly, 2026-01-31) — Other Equity Adjustments: 36601000.00
PATH income_statement (annual, 2026-01-31) — Other Gand A: 214291000.00
PATH income_statement (quarterly, 2026-01-31) — Other Gand A: 53548000.00
PATH income_statement (annual, 2026-01-31) — Other Income Expense: -4155000.00
PATH income_statement (quarterly, 2026-01-31) — Other Income Expense: 481000.00
PATH balance_sheet (annual, 2026-01-31) — Other Intangible Assets: 19989000.00
PATH balance_sheet (quarterly, 2026-01-31) — Other Intangible Assets: 19989000.00
PATH cash_flow (annual, 2026-01-31) — Other Non Cash Items: 137623000.00
PATH cash_flow (quarterly, 2026-01-31) — Other Non Cash Items: 38708000.00
PATH balance_sheet (annual, 2026-01-31) — Other Non Current Assets: 73425000.00
PATH balance_sheet (quarterly, 2026-01-31) — Other Non Current Assets: 73425000.00
PATH balance_sheet (annual, 2026-01-31) — Other Non Current Liabilities: 16682000.00
PATH balance_sheet (quarterly, 2026-01-31) — Other Non Current Liabilities: 16682000.00
PATH income_statement (annual, 2026-01-31) — Other Non Operating Income Expenses: -4155000.00
PATH income_statement (quarterly, 2026-01-31) — Other Non Operating Income Expenses: 481000.00
PATH balance_sheet (annual, 2026-01-31) — Other Properties: 65295000.00
PATH balance_sheet (quarterly, 2026-01-31) — Other Properties: 65295000.00
PATH balance_sheet (annual, 2026-01-31) — Other Receivables: 92440000.00
PATH balance_sheet (quarterly, 2026-01-31) — Other Receivables: 92440000.00
PATH balance_sheet (annual, 2026-01-31) — Other Short Term Investments: 601329000.00
PATH balance_sheet (quarterly, 2026-01-31) — Other Short Term Investments: 601329000.00
PATH balance_sheet (annual, 2026-01-31) — Payables: 66454000.00
PATH balance_sheet (quarterly, 2026-01-31) — Payables: 66454000.00
PATH balance_sheet (annual, 2026-01-31) — Payables And Accrued Expenses: 108541000.00
PATH balance_sheet (quarterly, 2026-01-31) — Payables And Accrued Expenses: 108541000.00
PATH balance_sheet (annual, 2026-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 124243000.00
PATH balance_sheet (quarterly, 2026-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 124243000.00
PATH balance_sheet (annual, 2026-01-31) — Preferred Stock: 0.00
PATH balance_sheet (quarterly, 2026-01-31) — Preferred Stock: 0.00
PATH balance_sheet (annual, 2026-01-31) — Prepaid Assets: 55332000.00
PATH balance_sheet (quarterly, 2026-01-31) — Prepaid Assets: 55332000.00
PATH income_statement (annual, 2026-01-31) — Pretax Income: 100628000.00
PATH income_statement (quarterly, 2026-01-31) — Pretax Income: 92437000.00
PATH cash_flow (annual, 2026-01-31) — Proceeds From Stock Option Exercised: 15915000.00
PATH cash_flow (quarterly, 2026-01-31) — Proceeds From Stock Option Exercised: 3084000.00
PATH balance_sheet (annual, 2026-01-31) — Properties: 0.00
PATH balance_sheet (quarterly, 2026-01-31) — Properties: 0.00
PATH cash_flow (annual, 2026-01-31) — Provisionand Write Offof Assets: 5735000.00
PATH cash_flow (annual, 2026-01-31) — Purchase Of Business: -24821000.00
PATH cash_flow (quarterly, 2026-01-31) — Purchase Of Business: 0.00
PATH cash_flow (annual, 2026-01-31) — Purchase Of Investment: -772491000.00
PATH cash_flow (quarterly, 2026-01-31) — Purchase Of Investment: -265252000.00
PATH cash_flow (annual, 2026-01-31) — Purchase Of PPE: -19048000.00
PATH cash_flow (quarterly, 2026-01-31) — Purchase Of PPE: -3052000.00
PATH balance_sheet (annual, 2026-01-31) — Receivables: 580705000.00
PATH balance_sheet (quarterly, 2026-01-31) — Receivables: 580705000.00
PATH income_statement (annual, 2026-01-31) — Reconciled Cost Of Revenue: 270984000.00
PATH income_statement (quarterly, 2026-01-31) — Reconciled Cost Of Revenue: 73935000.00
PATH income_statement (annual, 2026-01-31) — Reconciled Depreciation: 16969000.00
PATH income_statement (quarterly, 2026-01-31) — Reconciled Depreciation: 4973000.00
PATH cash_flow (annual, 2026-01-31) — Repurchase Of Capital Stock: -329101000.00
PATH cash_flow (quarterly, 2026-01-31) — Repurchase Of Capital Stock: 0.00
PATH income_statement (annual, 2026-01-31) — Research And Development: 385208000.00
PATH income_statement (quarterly, 2026-01-31) — Research And Development: 95159000.00
PATH balance_sheet (annual, 2026-01-31) — Restricted Cash: 438000.00
PATH balance_sheet (quarterly, 2026-01-31) — Restricted Cash: 438000.00
PATH balance_sheet (annual, 2026-01-31) — Retained Earnings: -1705545000.00
PATH balance_sheet (quarterly, 2026-01-31) — Retained Earnings: -1705545000.00
PATH cash_flow (annual, 2026-01-31) — Sale Of Investment: 809247000.00
PATH cash_flow (quarterly, 2026-01-31) — Sale Of Investment: 224166000.00
PATH income_statement (annual, 2026-01-31) — Selling And Marketing Expense: 683329000.00
PATH income_statement (quarterly, 2026-01-31) — Selling And Marketing Expense: 178179000.00
PATH income_statement (annual, 2026-01-31) — Selling General And Administration: 897620000.00
PATH income_statement (quarterly, 2026-01-31) — Selling General And Administration: 231727000.00
PATH balance_sheet (annual, 2026-01-31) — Share Issued: 605589000.00
PATH balance_sheet (quarterly, 2026-01-31) — Share Issued: 605589000.00
PATH cash_flow (annual, 2026-01-31) — Stock Based Compensation: 290676000.00
PATH cash_flow (quarterly, 2026-01-31) — Stock Based Compensation: 64834000.00
PATH balance_sheet (annual, 2026-01-31) — Stockholders Equity: 2082587000.00
PATH balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: 2082587000.00
PATH balance_sheet (annual, 2026-01-31) — Tangible Book Value: 1937288000.00
PATH balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: 1937288000.00
PATH income_statement (annual, 2026-01-31) — Tax Effect Of Unusual Items: 0.00
PATH income_statement (quarterly, 2026-01-31) — Tax Effect Of Unusual Items: 0.00
PATH income_statement (annual, 2026-01-31) — Tax Provision: -181702000.00
PATH income_statement (quarterly, 2026-01-31) — Tax Provision: -12025000.00
PATH income_statement (annual, 2026-01-31) — Tax Rate For Calcs: 0.40
PATH income_statement (quarterly, 2026-01-31) — Tax Rate For Calcs: 0.40
PATH balance_sheet (annual, 2026-01-31) — Total Assets: 3179200000.00
PATH balance_sheet (quarterly, 2026-01-31) — Total Assets: 3179200000.00
PATH balance_sheet (annual, 2026-01-31) — Total Capitalization: 2082587000.00
PATH balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 2082587000.00
PATH balance_sheet (annual, 2026-01-31) — Total Debt: 81246000.00
PATH balance_sheet (quarterly, 2026-01-31) — Total Debt: 81246000.00
PATH balance_sheet (annual, 2026-01-31) — Total Equity Gross Minority Interest: 2082587000.00
PATH balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 2082587000.00
PATH income_statement (annual, 2026-01-31) — Total Expenses: 1553812000.00
PATH income_statement (quarterly, 2026-01-31) — Total Expenses: 400821000.00
PATH balance_sheet (annual, 2026-01-31) — Total Liabilities Net Minority Interest: 1096613000.00
PATH balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 1096613000.00
PATH balance_sheet (annual, 2026-01-31) — Total Non Current Assets: 935255000.00
PATH balance_sheet (quarterly, 2026-01-31) — Total Non Current Assets: 935255000.00
PATH balance_sheet (annual, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 191190000.00
PATH balance_sheet (quarterly, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 191190000.00
PATH income_statement (annual, 2026-01-31) — Total Operating Income As Reported: 56760000.00
PATH income_statement (quarterly, 2026-01-31) — Total Operating Income As Reported: 80286000.00
PATH balance_sheet (annual, 2026-01-31) — Total Tax Payable: 43948000.00
PATH balance_sheet (quarterly, 2026-01-31) — Total Tax Payable: 43948000.00
PATH balance_sheet (annual, 2026-01-31) — Treasury Shares Number: 68552000.00
PATH balance_sheet (quarterly, 2026-01-31) — Treasury Shares Number: 68552000.00
PATH balance_sheet (annual, 2026-01-31) — Treasury Stock: 833905000.00
PATH balance_sheet (quarterly, 2026-01-31) — Treasury Stock: 833905000.00
PATH balance_sheet (annual, 2026-01-31) — Working Capital: 1338522000.00
PATH balance_sheet (quarterly, 2026-01-31) — Working Capital: 1338522000.00
PATH income_statement (quarterly, 2026-04-30) — +Operating Expense: 313467000.00
PATH income_statement (quarterly, 2026-04-30) — +Total Revenue: 418382000.00
PATH balance_sheet (quarterly, 2026-04-30) — Accounts Payable: 19699000.00
PATH balance_sheet (quarterly, 2026-04-30) — Accounts Receivable: 299999000.00
PATH balance_sheet (quarterly, 2026-04-30) — Accumulated Depreciation: -48811000.00
PATH balance_sheet (quarterly, 2026-04-30) — Additional Paid In Capital: 4628200000.00
PATH balance_sheet (quarterly, 2026-04-30) — Allowance For Doubtful Accounts Receivable: -5468000.00
PATH cash_flow (quarterly, 2026-04-30) — Amortization Of Securities: -701000.00
PATH balance_sheet (quarterly, 2026-04-30) — Available For Sale Securities: 108502000.00
PATH income_statement (quarterly, 2026-04-30) — Basic Average Shares: 523584000.00
PATH income_statement (quarterly, 2026-04-30) — Basic EPS: 0.04
PATH cash_flow (quarterly, 2026-04-30) — Beginning Cash Position: 871595000.00
PATH cash_flow (quarterly, 2026-04-30) — Capital Expenditure: -2684000.00
PATH balance_sheet (quarterly, 2026-04-30) — Capital Lease Obligations: 83003000.00
PATH balance_sheet (quarterly, 2026-04-30) — Capital Stock: 6000.00
PATH balance_sheet (quarterly, 2026-04-30) — Cash And Cash Equivalents: 632195000.00
PATH balance_sheet (quarterly, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 1307244000.00
PATH cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Financing Activities: -252191000.00
PATH cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Investing Activities: -112841000.00
PATH cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Operating Activities: 131928000.00
PATH cash_flow (quarterly, 2026-04-30) — Change In Account Payable: 9390000.00
PATH cash_flow (quarterly, 2026-04-30) — Change In Accrued Expense: -86053000.00
PATH cash_flow (quarterly, 2026-04-30) — Change In Other Current Liabilities: -4458000.00
PATH cash_flow (quarterly, 2026-04-30) — Change In Other Working Capital: -82068000.00
PATH cash_flow (quarterly, 2026-04-30) — Change In Payable: 9390000.00
PATH cash_flow (quarterly, 2026-04-30) — Change In Payables And Accrued Expense: -76663000.00
PATH cash_flow (quarterly, 2026-04-30) — Change In Prepaid Assets: -12870000.00
PATH cash_flow (quarterly, 2026-04-30) — Change In Receivables: 180888000.00
PATH cash_flow (quarterly, 2026-04-30) — Change In Working Capital: 4829000.00
PATH cash_flow (quarterly, 2026-04-30) — Changes In Account Receivables: 194865000.00
PATH cash_flow (quarterly, 2026-04-30) — Changes In Cash: -233104000.00
PATH balance_sheet (quarterly, 2026-04-30) — Common Stock: 6000.00
PATH balance_sheet (quarterly, 2026-04-30) — Common Stock Equity: 1902965000.00
PATH cash_flow (quarterly, 2026-04-30) — Common Stock Payments: -243796000.00
PATH balance_sheet (quarterly, 2026-04-30) — Construction In Progress: 1909000.00
PATH income_statement (quarterly, 2026-04-30) — Cost Of Revenue: 76928000.00
PATH balance_sheet (quarterly, 2026-04-30) — Current Accrued Expenses: 31915000.00
PATH balance_sheet (quarterly, 2026-04-30) — Current Assets: 1918362000.00
PATH balance_sheet (quarterly, 2026-04-30) — Current Capital Lease Obligation: 11012000.00
PATH balance_sheet (quarterly, 2026-04-30) — Current Debt And Capital Lease Obligation: 11012000.00
PATH balance_sheet (quarterly, 2026-04-30) — Current Deferred Assets: 86624000.00
PATH balance_sheet (quarterly, 2026-04-30) — Current Deferred Liabilities: 577849000.00
PATH balance_sheet (quarterly, 2026-04-30) — Current Deferred Revenue: 572072000.00
PATH balance_sheet (quarterly, 2026-04-30) — Current Liabilities: 831666000.00
PATH cash_flow (quarterly, 2026-04-30) — Deferred Income Tax: 11391000.00
PATH cash_flow (quarterly, 2026-04-30) — Deferred Tax: 11391000.00
PATH cash_flow (quarterly, 2026-04-30) — Depreciation Amortization Depletion: 7509000.00
PATH cash_flow (quarterly, 2026-04-30) — Depreciation And Amortization: 7509000.00
PATH income_statement (quarterly, 2026-04-30) — Diluted Average Shares: 527818000.00
PATH income_statement (quarterly, 2026-04-30) — Diluted EPS: 0.04
PATH income_statement (quarterly, 2026-04-30) — Diluted NI Availto Com Stockholders: 22525000.00
PATH balance_sheet (quarterly, 2026-04-30) — Dueto Related Parties Current: 12546000.00
PATH income_statement (quarterly, 2026-04-30) — EBIT: 27987000.00
PATH income_statement (quarterly, 2026-04-30) — EBITDA: 35496000.00
PATH cash_flow (quarterly, 2026-04-30) — Effect Of Exchange Rate Changes: -4821000.00
PATH cash_flow (quarterly, 2026-04-30) — End Cash Position: 633670000.00
PATH cash_flow (quarterly, 2026-04-30) — Financing Cash Flow: -252191000.00
PATH cash_flow (quarterly, 2026-04-30) — Free Cash Flow: 129244000.00
PATH balance_sheet (quarterly, 2026-04-30) — Gains Losses Not Affecting Retained Earnings: 27374000.00
PATH income_statement (quarterly, 2026-04-30) — General And Administrative Expense: 52706000.00
PATH balance_sheet (quarterly, 2026-04-30) — Goodwill: 185695000.00
PATH balance_sheet (quarterly, 2026-04-30) — Goodwill And Other Intangible Assets: 285815000.00
PATH balance_sheet (quarterly, 2026-04-30) — Gross Accounts Receivable: 305467000.00
PATH balance_sheet (quarterly, 2026-04-30) — Gross PPE: 160816000.00
PATH income_statement (quarterly, 2026-04-30) — Gross Profit: 341454000.00
PATH cash_flow (quarterly, 2026-04-30) — Income Tax Paid Supplemental Data: 4974000.00
PATH balance_sheet (quarterly, 2026-04-30) — Income Tax Payable: 10632000.00
PATH income_statement (quarterly, 2026-04-30) — Interest Income: 10401000.00
PATH income_statement (quarterly, 2026-04-30) — Interest Income Non Operating: 10401000.00
PATH balance_sheet (quarterly, 2026-04-30) — Invested Capital: 1902965000.00
PATH cash_flow (quarterly, 2026-04-30) — Investing Cash Flow: -112841000.00
PATH balance_sheet (quarterly, 2026-04-30) — Investmentin Financial Assets: 108502000.00
PATH balance_sheet (quarterly, 2026-04-30) — Investments And Advances: 108502000.00
PATH balance_sheet (quarterly, 2026-04-30) — Leases: 56085000.00
PATH balance_sheet (quarterly, 2026-04-30) — Long Term Capital Lease Obligation: 71991000.00
PATH balance_sheet (quarterly, 2026-04-30) — Long Term Debt And Capital Lease Obligation: 71991000.00
PATH balance_sheet (quarterly, 2026-04-30) — Machinery Furniture Equipment: 35598000.00
PATH cash_flow (quarterly, 2026-04-30) — Net Business Purchase And Sale: -149403000.00
PATH cash_flow (quarterly, 2026-04-30) — Net Common Stock Issuance: -243796000.00
PATH income_statement (quarterly, 2026-04-30) — Net Income: 22525000.00
PATH income_statement (quarterly, 2026-04-30) — Net Income Common Stockholders: 22525000.00
PATH income_statement (quarterly, 2026-04-30) — Net Income Continuous Operations: 22525000.00
PATH income_statement (quarterly, 2026-04-30) — Net Income From Continuing And Discontinued Operation: 22525000.00
PATH income_statement (quarterly, 2026-04-30) — Net Income From Continuing Operation Net Minority Interest: 22525000.00
PATH cash_flow (quarterly, 2026-04-30) — Net Income From Continuing Operations: 22525000.00
PATH income_statement (quarterly, 2026-04-30) — Net Income Including Noncontrolling Interests: 22525000.00
PATH income_statement (quarterly, 2026-04-30) — Net Interest Income: 10401000.00
PATH cash_flow (quarterly, 2026-04-30) — Net Investment Purchase And Sale: 34621000.00
PATH income_statement (quarterly, 2026-04-30) — Net Non Operating Interest Income Expense: 10401000.00
PATH cash_flow (quarterly, 2026-04-30) — Net Other Financing Charges: -12770000.00
PATH cash_flow (quarterly, 2026-04-30) — Net Other Investing Changes: 4625000.00
PATH balance_sheet (quarterly, 2026-04-30) — Net PPE: 112005000.00
PATH cash_flow (quarterly, 2026-04-30) — Net PPE Purchase And Sale: -2684000.00
PATH balance_sheet (quarterly, 2026-04-30) — Net Tangible Assets: 1617150000.00
PATH balance_sheet (quarterly, 2026-04-30) — Non Current Accounts Receivable: 2923000.00
PATH balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Assets: 404754000.00
PATH balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Liabilities: 86173000.00
PATH balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Revenue: 86173000.00
PATH balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Taxes Assets: 249522000.00
PATH income_statement (quarterly, 2026-04-30) — Normalized EBITDA: 35496000.00
PATH income_statement (quarterly, 2026-04-30) — Normalized Income: 22525000.00
PATH cash_flow (quarterly, 2026-04-30) — Operating Cash Flow: 131928000.00
PATH income_statement (quarterly, 2026-04-30) — Operating Income: 27987000.00
PATH income_statement (quarterly, 2026-04-30) — Operating Revenue: 418382000.00
PATH balance_sheet (quarterly, 2026-04-30) — Ordinary Shares Number: 520452706.00
PATH balance_sheet (quarterly, 2026-04-30) — Other Current Assets: 48488000.00
PATH balance_sheet (quarterly, 2026-04-30) — Other Current Liabilities: 68732000.00
PATH balance_sheet (quarterly, 2026-04-30) — Other Equity Adjustments: 27374000.00
PATH income_statement (quarterly, 2026-04-30) — Other Gand A: 52706000.00
PATH income_statement (quarterly, 2026-04-30) — Other Income Expense: 2580000.00
PATH balance_sheet (quarterly, 2026-04-30) — Other Intangible Assets: 100120000.00
PATH cash_flow (quarterly, 2026-04-30) — Other Non Cash Items: 33065000.00
PATH balance_sheet (quarterly, 2026-04-30) — Other Non Current Assets: 72339000.00
PATH balance_sheet (quarterly, 2026-04-30) — Other Non Current Liabilities: 11905000.00
PATH income_statement (quarterly, 2026-04-30) — Other Non Operating Income Expenses: 2580000.00
PATH balance_sheet (quarterly, 2026-04-30) — Other Properties: 67224000.00
PATH balance_sheet (quarterly, 2026-04-30) — Other Receivables: 110235000.00
PATH balance_sheet (quarterly, 2026-04-30) — Other Short Term Investments: 675049000.00
PATH balance_sheet (quarterly, 2026-04-30) — Payables: 73755000.00
PATH balance_sheet (quarterly, 2026-04-30) — Payables And Accrued Expenses: 105670000.00
PATH balance_sheet (quarterly, 2026-04-30) — Pensionand Other Post Retirement Benefit Plans Current: 68403000.00
PATH balance_sheet (quarterly, 2026-04-30) — Preferred Stock: 0.00
PATH balance_sheet (quarterly, 2026-04-30) — Prepaid Assets: 64297000.00
PATH income_statement (quarterly, 2026-04-30) — Pretax Income: 40968000.00
PATH cash_flow (quarterly, 2026-04-30) — Proceeds From Stock Option Exercised: 4375000.00
PATH balance_sheet (quarterly, 2026-04-30) — Properties: 0.00
PATH cash_flow (quarterly, 2026-04-30) — Purchase Of Business: -149403000.00
PATH cash_flow (quarterly, 2026-04-30) — Purchase Of Investment: -154971000.00
PATH cash_flow (quarterly, 2026-04-30) — Purchase Of PPE: -2684000.00
PATH balance_sheet (quarterly, 2026-04-30) — Receivables: 410234000.00
PATH income_statement (quarterly, 2026-04-30) — Reconciled Cost Of Revenue: 76928000.00
PATH income_statement (quarterly, 2026-04-30) — Reconciled Depreciation: 7509000.00
PATH cash_flow (quarterly, 2026-04-30) — Repurchase Of Capital Stock: -243796000.00
PATH income_statement (quarterly, 2026-04-30) — Research And Development: 92902000.00
PATH balance_sheet (quarterly, 2026-04-30) — Restricted Cash: 1475000.00
PATH balance_sheet (quarterly, 2026-04-30) — Retained Earnings: -1683020000.00
PATH cash_flow (quarterly, 2026-04-30) — Sale Of Investment: 189592000.00
PATH income_statement (quarterly, 2026-04-30) — Selling And Marketing Expense: 167859000.00
PATH income_statement (quarterly, 2026-04-30) — Selling General And Administration: 220565000.00
PATH balance_sheet (quarterly, 2026-04-30) — Share Issued: 609379706.00
PATH cash_flow (quarterly, 2026-04-30) — Stock Based Compensation: 53310000.00
PATH balance_sheet (quarterly, 2026-04-30) — Stockholders Equity: 1902965000.00
PATH balance_sheet (quarterly, 2026-04-30) — Tangible Book Value: 1617150000.00
PATH income_statement (quarterly, 2026-04-30) — Tax Effect Of Unusual Items: 0.00
PATH income_statement (quarterly, 2026-04-30) — Tax Provision: 18443000.00
PATH income_statement (quarterly, 2026-04-30) — Tax Rate For Calcs: 0.40
PATH balance_sheet (quarterly, 2026-04-30) — Total Assets: 2904700000.00
PATH balance_sheet (quarterly, 2026-04-30) — Total Capitalization: 1902965000.00
PATH balance_sheet (quarterly, 2026-04-30) — Total Debt: 83003000.00
PATH balance_sheet (quarterly, 2026-04-30) — Total Equity Gross Minority Interest: 1902965000.00
PATH income_statement (quarterly, 2026-04-30) — Total Expenses: 390395000.00
PATH balance_sheet (quarterly, 2026-04-30) — Total Liabilities Net Minority Interest: 1001735000.00
PATH balance_sheet (quarterly, 2026-04-30) — Total Non Current Assets: 986338000.00
PATH balance_sheet (quarterly, 2026-04-30) — Total Non Current Liabilities Net Minority Interest: 170069000.00
PATH income_statement (quarterly, 2026-04-30) — Total Operating Income As Reported: 27987000.00
PATH balance_sheet (quarterly, 2026-04-30) — Total Tax Payable: 41510000.00
PATH balance_sheet (quarterly, 2026-04-30) — Treasury Shares Number: 88927000.00
PATH balance_sheet (quarterly, 2026-04-30) — Treasury Stock: 1069595000.00
PATH balance_sheet (quarterly, 2026-04-30) — Working Capital: 1086696000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -387901000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 375125000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 198532000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 325000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 120823000.00
PATINTLOG.NS cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -2604000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 7580000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 2381000.00
PATINTLOG.NS income_statement (annual, 2022-03-31) — Interest Income: 14339000.00
PATINTLOG.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 14339000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 245490000.00
PATINTLOG.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -5192000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 458146000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Net Debt: 358697000.00
PATINTLOG.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: -68099000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 32849000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 20221000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 3354000.00
PATINTLOG.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 21909000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Other Payable: 12204000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 2065000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 7580000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 81964000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
PATINTLOG.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 7923000.00
PATINTLOG.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 7923000.00
PATINTLOG.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: -5192000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 95582000.00
PATINTLOG.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 80793000.00
PATINTLOG.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 727000.00
PATINTLOG.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 5143000.00
PATINTLOG.NS income_statement (annual, 2022-03-31) — Write Off: 101046000.00
PATINTLOG.NS income_statement (annual, 2023-03-31) — +Operating Expense: 29586000.00
PATINTLOG.NS income_statement (annual, 2023-03-31) — +Total Revenue: 2778563000.00
PATINTLOG.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 109281000.00
PATINTLOG.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 738553000.00
PATINTLOG.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -413739000.00
PATINTLOG.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 371702000.00
PATINTLOG.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 625000.00
PATINTLOG.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 27025000.00
PATINTLOG.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 44312905.00
PATINTLOG.NS income_statement (annual, 2023-03-31) — Basic EPS: 1.11
PATINTLOG.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: -167594000.00
PATINTLOG.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 199113000.00
PATINTLOG.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -11551000.00
PATINTLOG.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 649483000.00
PATINTLOG.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 191295000.00
PATINTLOG.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 216141000.00
PATINTLOG.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -3604000.00
PATINTLOG.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 120725000.00